Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080
3/4/2013 11:46:40 AM
More...
|
Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation
6/12/2012 7:47:36 AM
More...
|
Axxam srl and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU
7/27/2011 9:32:12 AM
More...
|
Polyphor Announces First PEMfinder(R) collaboration with Big Pharma, Novartis Pharmaceuticals Corporation (NVS)
5/6/2010 10:52:14 AM
More...
|
Polyphor And University of Zurich Discovers A New Class Of Antibiotics With A Novel Mode Of Action
2/23/2010 11:21:17 AM
More...
|
Polyphor Discovers a New Class of Antibiotics with a Novel Mode of Action
2/19/2010 9:56:16 AM
More...
|
Polyphor to Enter into an Exclusive Agreement with Allergan Inc. (AGN) for the Development of Protein Epitope Mimetics (PEM) Inhibitors for Ophthalmology; Allergan Entitled to Receive up to $61.0 Million
10/31/2008 6:27:13 AM
More...
|
Polyphor Successfully Completes Phase I Clinical Trials of POL6326
7/9/2008 11:15:33 AM
More...
|